Pro-Dex (co) Overview
Pro-Dex (co) (PDEX) has a ROE of 28.68%, above the Healthcare sector average of 20.86%.
Get informed when a big investor buys or sells
+ Follow28.68%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for PDEX is 28.68%. That is above the Healthcare sector average of 20.86%. Investors often review this figure alongside Pro-Dex (co)'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, PDEX currently prints 28.68% for ROE, while the sector average sits near 20.86%. That is roughly 37.5% above the sector mean. Large gaps often invite a closer look at Pro-Dex (co)'s growth, margins, and balance sheet.
Return on Equity shows how effectively Pro-Dex (co) converts resources into returns. At 28.68%, PDEX may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting PDEX's ROE (28.68%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Pro-Dex (co)'s ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
